Skip to main content
PBM
NASDAQ Life Sciences

Psyence Biomed Exports GMP Psilocybin to Australia for Phase IIb Trial

Tom Rudovsky · Reported by Reuters
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$2.28
Mkt Cap
$2.617M
52W Low
$1.92
52W High
$74.938
52W Position info
19% above low
Off High info
97% below high
Rel. Volume info
0.1× avg
Market data snapshot near publication time

PBM sits 19% above its 52-week low of $1.92 on light trading volume (0.1× avg).

Summary

Psyence Biomedical announced the successful export of its GMP-manufactured natural psilocybin (NPX-5) to Australia, designated for an ongoing Phase IIb clinical trial. This development marks a significant operational and regulatory milestone, distinct from the company's recent financing activities. For a micro-cap life sciences company, advancing a drug candidate into and through a Phase IIb trial is a critical de-risking event that validates its pipeline and moves it closer to potential commercialization. Traders will view this as a positive step, and attention will now turn to the trial's progress and future data readouts.

At the time of this announcement, PBM was trading at $2.28 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $2.6M. The 52-week trading range was $1.92 to $74.94. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Reuters.


Price Chart

Share this article

Copied!

PBM - Latest Insights

PBM
Oct 21, 2026, 7:00 AM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $4.09
Real-time Price: $2.99 info
Change: -$1.10 (-27%) info
Market Cap: $11.405M info
PBM
Oct 15, 2026, 9:03 AM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
7
Price at Filing: $4.00
Real-time Price: $2.99 info
Change: -$1.01 (-25%) info
Market Cap: $11.405M info
PBM
Oct 05, 2026, 7:00 AM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $5.35
Real-time Price: $2.99 info
Change: -$2.36 (-44%) info
Market Cap: $11.405M info
PBM
Sep 28, 2026, 7:00 AM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $5.86
Real-time Price: $2.99 info
Change: -$2.87 (-49%) info
Market Cap: $11.405M info
PBM
Sep 23, 2026, 7:00 AM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $6.42
Real-time Price: $2.99 info
Change: -$3.43 (-53%) info
Market Cap: $11.405M info